QCI Interpret for Oncology

Agilent Alissa to QCI Interpret: How can your lab reduce the stress and complexity of transitioning to a new clinical informatics platform?

March 26, 2024
In 2023, Agilent announced the discontinuation of their Alissa Interpret clinical informatics platform by the end of 2024. As a result, many of their current customers need to transition to a new variant interpretation and reporting software within a tight timeframe. However, when evaluating new interpretation solutions, clinical labs must consider a variety of factors, including:

Content quality for clinical reporting
Flexibility to adapt current workflows to a new platform
Retaining historical content and comments
Ease of personnel training

In this webinar, learn about QCI Interpret, a panel- and sequencer-agnostic clinical informatics platform for NGS variant interpretation and reporting of germline and somatic tests. Our experts will address the concerns of current Alissa users and discuss what sets QCI Interpret apart from other interpretation solutions. In addition, we will show you how seamless it is to transition to QCI Interpret, as well as provide a live demonstration of the industry-leading and reliable software that has been used to analyze and interpret more than 3.5 million patient test cases worldwide.

Related videos

QCI Interpret for Oncology

FASTQ to final report: Ultra-fast workflow for CGP

381 views July 21, 2022

As our molecular knowledge of cancer continually evolves, a new era in cancer...

QCI Interpret for Oncology

Comprehensive Molecular Tumor Analysis with Alacris Theranostics

283 views March 09, 2023

Precision oncology approaches have made great strides harnessing individual...

QCI Interpret for Oncology

Comparison of methods in routine somatic diagnostics

256 views April 12, 2022

Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular...

QCI Interpret for Oncology

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

232 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...